February 15, 2022

U.S. Hemp Roundtable Statement Concerning Confirmation Of Robert Califf As FDA Commissioner

U.S. Hemp Roundtable Statement Concerning Confirmation Of Robert Califf As FDA Commissioner

(WASHINGTON D.C.) – The U.S. hemp industry congratulates Dr. Califf for his confirmation to the critical position of Commissioner of the Food and Drug Administration, and we look forward to working with him to advance the health and safety of American consumers. We also offer him a recommendation that will assist him in bolstering the FDA’s credibility in the aftermath of the opioid epidemic and the COVID pandemic: directing the agency to finally regulate the growing hemp and CBD marketplace. It’s been more than three years since the enactment of the 2018 Farm Bill, which explicitly legalized hemp and clarified the FDA’s jurisdiction over ingestible and topical hemp products. Meanwhile, since the agency is not ensuring that products sold under the hemp name are in compliance with federal regulations, many products continue to be sold that raise significant quality, safety, intoxication, and other consumer protection concerns. Commissioner Califf could exercise existing authority to apply the same regulations to hemp as it does for all other dietary supplements and food and beverage additives. Doing so would take a small step towards restoring public trust in the agency.

– Jonathan Miller, U.S. Hemp Roundtable General Counsel


The U.S. Hemp Roundtable is the hemp industry’s national advocacy organization, a coalition of dozens of leading companies and organizations committed to safe hemp and CBD products. The Roundtable proudly works in partnership with the industry’s leading national, regional and state grassroots organizations, and is leading the way forward for hemp and CBD products through education and action. More at



Alyssa Erickson, Public Affairs & Marketing Coordinator

[email protected]

[email protected]

Download PDF